These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1143 related items for PubMed ID: 27375134

  • 1. The gamma-glutamyl transpeptidase-to-platelet ratio predicts liver fibrosis and cirrhosis in HBeAg-positive chronic HBV infection patients with high HBV DNA and normal or mildly elevated alanine transaminase levels in China.
    Li Q, Li W, Huang Y, Chen L.
    J Viral Hepat; 2016 Nov; 23(11):912-919. PubMed ID: 27375134
    [Abstract] [Full Text] [Related]

  • 2. The gamma-glutamyl transpeptidase to platelet ratio for non-invasive assessment of liver fibrosis in patients with chronic hepatitis B and non-alcoholic fatty liver disease.
    Li Q, Lu C, Li W, Huang Y, Chen L.
    Oncotarget; 2017 Apr 25; 8(17):28641-28649. PubMed ID: 28415736
    [Abstract] [Full Text] [Related]

  • 3. Comparative evaluation of GPR versus APRI and FIB-4 in predicting different levels of liver fibrosis of chronic hepatitis B.
    Liu DP, Lu W, Zhang ZQ, Wang YB, Ding RR, Zhou XL, Huang D, Li XF.
    J Viral Hepat; 2018 May 25; 25(5):581-589. PubMed ID: 29230907
    [Abstract] [Full Text] [Related]

  • 4. Globulin-platelet model predicts significant fibrosis and cirrhosis in CHB patients with high HBV DNA and mildly elevated alanine transaminase levels.
    Li Q, Lu C, Li W, Huang Y, Chen L.
    Clin Exp Med; 2018 Feb 25; 18(1):71-78. PubMed ID: 28884309
    [Abstract] [Full Text] [Related]

  • 5. The Gamma-Glutamyl-Transpeptidase to Platelet Ratio Does not Show Advantages than APRI and Fib-4 in Diagnosing Significant Fibrosis and Cirrhosis in Patients With Chronic Hepatitis B: A Retrospective Cohort Study in China.
    Li Q, Song J, Huang Y, Li X, Zhuo Q, Li W, Chen C, Lu C, Qi X, Chen L.
    Medicine (Baltimore); 2016 Apr 25; 95(16):e3372. PubMed ID: 27100421
    [Abstract] [Full Text] [Related]

  • 6. Comparison and evaluation of non-invasive models in predicting liver inflammation and fibrosis of chronic hepatitis B virus-infected patients with high hepatitis B virus DNA and normal or mildly elevated alanine transaminase levels.
    Wang L, Li J, Yang K, Zhang H, Wang Q, Lv X, Guan S.
    Medicine (Baltimore); 2020 Jun 05; 99(23):e20548. PubMed ID: 32502018
    [Abstract] [Full Text] [Related]

  • 7. The gamma-glutamyl transpeptidase to platelet ratio (GPR) predicts significant liver fibrosis and cirrhosis in patients with chronic HBV infection in West Africa.
    Lemoine M, Shimakawa Y, Nayagam S, Khalil M, Suso P, Lloyd J, Goldin R, Njai HF, Ndow G, Taal M, Cooke G, D'Alessandro U, Vray M, Mbaye PS, Njie R, Mallet V, Thursz M.
    Gut; 2016 Aug 05; 65(8):1369-76. PubMed ID: 26109530
    [Abstract] [Full Text] [Related]

  • 8. Value of gamma-glutamyltranspeptidase-to-platelet ratio in diagnosis of hepatic fibrosis in patients with chronic hepatitis B.
    Hu YC, Liu H, Liu XY, Ma LN, Guan YH, Luo X, Ding XC.
    World J Gastroenterol; 2017 Nov 07; 23(41):7425-7432. PubMed ID: 29151696
    [Abstract] [Full Text] [Related]

  • 9. Noninvasive models for the prediction of liver fibrosis in patients with chronic hepatitis B.
    Wang J, Sun X, Wei S, Chen X, Zhu H, Liantang Y, Bao R, Du Y.
    BMC Gastroenterol; 2024 May 24; 24(1):183. PubMed ID: 38783185
    [Abstract] [Full Text] [Related]

  • 10. Evaluation of APRI and FIB-4 for noninvasive assessment of significant fibrosis and cirrhosis in HBeAg-negative CHB patients with ALT ≤ 2 ULN: A retrospective cohort study.
    Li Q, Ren X, Lu C, Li W, Huang Y, Chen L.
    Medicine (Baltimore); 2017 Mar 24; 96(12):e6336. PubMed ID: 28328813
    [Abstract] [Full Text] [Related]

  • 11. Accuracy of international guidelines for identifying significant fibrosis in hepatitis B e antigen--negative patients with chronic hepatitis.
    Sanai FM, Babatin MA, Bzeizi KI, Alsohaibani F, Al-Hamoudi W, Alsaad KO, Al Mana H, Handoo FA, Al-Ashgar H, Alghamdi H, Ibrahim A, Aljumah A, Alalwan A, Altraif IH, Al-Hussaini H, Myers RP, Abdo AA.
    Clin Gastroenterol Hepatol; 2013 Nov 24; 11(11):1493-1499.e2. PubMed ID: 23811251
    [Abstract] [Full Text] [Related]

  • 12. The gamma-glutamyl transpeptidase to platelet ratio predicts liver inflammation in chronic hepatitis B with normal or mildly elevated alanine transaminase.
    Wang J, Xia J, Yan X, Yang Y, Wei J, Xiong Y, Wu W, Liu Y, Chen Y, Jia B, Chen Z, Zhang Z, Ding W, Huang R, Wu C.
    Clin Res Hepatol Gastroenterol; 2020 Nov 24; 44(6):913-922. PubMed ID: 32147439
    [Abstract] [Full Text] [Related]

  • 13. Relationship between virological response and FIB-4 index in chronic hepatitis B patients with entecavir therapy.
    Li N, Xu JH, Yu M, Wang S, Si CW, Yu YY.
    World J Gastroenterol; 2015 Nov 21; 21(43):12421-9. PubMed ID: 26604649
    [Abstract] [Full Text] [Related]

  • 14. Aspartate aminotransferase to platelet ratio can reduce the need for transient elastography in Chinese patients with chronic hepatitis B.
    Yue W, Li Y, Geng J, Wang P, Zhang L.
    Medicine (Baltimore); 2019 Dec 21; 98(49):e18038. PubMed ID: 31804310
    [Abstract] [Full Text] [Related]

  • 15. Gamma-glutamyl-transpeptidase to platelet ratio is not superior to APRI,FIB-4 and RPR for diagnosing liver fibrosis in CHB patients in China.
    Huang R, Wang G, Tian C, Liu Y, Jia B, Wang J, Yang Y, Li Y, Sun Z, Yan X, Xia J, Xiong Y, Song P, Zhang Z, Ding W, Wu C.
    Sci Rep; 2017 Aug 17; 7(1):8543. PubMed ID: 28819319
    [Abstract] [Full Text] [Related]

  • 16. The gamma-glutamyl transpeptidase-to-albumin ratio predicts significant fibrosis and cirrhosis in chronic hepatitis B patients.
    Li Q, Lu C, Li W, Huang Y, Chen L.
    J Viral Hepat; 2017 Dec 17; 24(12):1143-1150. PubMed ID: 28685907
    [Abstract] [Full Text] [Related]

  • 17. Gamma-glutamyl transpeptidase to cholinesterase and platelet ratio in predicting significant liver fibrosis and cirrhosis of chronic hepatitis B.
    Liu D, Li J, Lu W, Wang Y, Zhou X, Huang D, Li X, Ding R, Zhang Z.
    Clin Microbiol Infect; 2019 Apr 17; 25(4):514.e1-514.e8. PubMed ID: 29906588
    [Abstract] [Full Text] [Related]

  • 18. The gamma-glutamyl transferase to platelet ratio and the FIB-4 score are noninvasive markers to determine the severity of liver fibrosis in chronic hepatitis B infection.
    Lee J, Kim MY, Kang SH, Kim J, Uh Y, Yoon KJ, Kim HS.
    Br J Biomed Sci; 2018 Jul 17; 75(3):128-132. PubMed ID: 29893189
    [Abstract] [Full Text] [Related]

  • 19. Serum N-glycan markers for diagnosing liver fibrosis induced by hepatitis B virus.
    Cao X, Shang QH, Chi XL, Zhang W, Xiao HM, Sun MM, Chen G, An Y, Lv CL, Wang L, Nan YM, Chen CY, Tan ZN, Liu XE, Zhuang H.
    World J Gastroenterol; 2020 Mar 14; 26(10):1067-1079. PubMed ID: 32205997
    [Abstract] [Full Text] [Related]

  • 20. Aspartate transaminase to platelet ratio index and gamma-glutamyl transpeptidase-to-platelet ratio outweigh fibrosis index based on four factors and red cell distribution width-platelet ratio in diagnosing liver fibrosis and inflammation in chronic hepatitis B.
    Wu X, Cai B, Su Z, Li Y, Xu J, Deng R, Wang L.
    J Clin Lab Anal; 2018 May 14; 32(4):e22341. PubMed ID: 29251384
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 58.